STAT+: Recursion, the AI drug development company, cuts more jobs after finalizing Exscientia merger

Recursion Pharmaceuticals, one of the most advanced companies using artificial intelligence and machine learning tools to expedite drug development, laid off employees after closing a merger last week.

Continue to STAT+ to read the full story…